Infectious complications of blood transfusion

Dienstag, 1980, Non-A, non-B hepatitis, Advances in Internal Medicine, 26, 187 Senior, 1974, Reduction of post-transfusion hepatitis by exclusion of Australia antigen from donor blood in an urban public school, American Journal of Medical Sciences, 267, 171, 10.1097/00000441-197403000-00004 Goldfield, 1975, The consequences of administering blood pretested for HB Ag by third generation techniques: A progress report, American Journal of Medical Sciences, 270, 335, 10.1097/00000441-197509000-00015 Knodell, 1975, Etiological spectrum of post-transfusion hepatitis, Gastroenterology, 69, 1278, 10.1016/S0016-5085(19)32325-X Alter, 1978, Non-A/non-B hepatitis: A review and interim report of an ongoing prospective study, 359 Seeff, 1978, Posttransfusion hepatitis, 1973–1975: A Veterans Administration cooperative study, 371 Alter, 1981, Donor transaminase and recipient hepatitis: Impact on blood transfusion services, Journal of the American Medical Association, 246, 630, 10.1001/jama.246.6.630 Aach, 1981, Serum alanine aminotransferase of donors in relation to the risk of non-A, non-B hepatitis in recipients: The transfusion-transmitted virus study, New England Journal of Medicine, 304, 989, 10.1056/NEJM198104233041701 Koretz, 1980, The long-term course of non-A, non-B post-transfusion hepatitis, Gastroenterology, 79, 893, 10.1016/0016-5085(80)90447-3 Purcel, 1976, Non-A, non-B hepatitis, Yale Journal of Biology and Medicine, 49, 243 Bradley, 1979, Experimental infection of chimpanzees with antihemophilic (factor VIII) materials: Recovery of virus-like particles associated with non-A, non-B hepatitis, Journal of Medical Virology, 3, 253, 10.1002/jmv.1890030403 Deinhardt, 1980, Predictive value of markers of hepatitis virus infection, Journal of Infectious Diseases, 141, 299, 10.1093/infdis/141.3.299 Dienstag, 1977, Etiology of sporadic hepatitis B surface antigen-negative hepatitis, Annals of Internal Medicine, 87, 1, 10.7326/0003-4819-87-1-1 Hoofnagle, 1981, Serological tests for non-A, non-B hepatitis, Liver, 1, 177, 10.1111/j.1600-0676.1981.tb00031.x Tabor, 1984, Additional evidence for more than one agent of human non-A, non-B hepatitis, Transfusion, 24, 224, 10.1046/j.1537-2995.1984.24384225027.x Shimizu, 1979, Non-A, non-B hepatitis: Ultrastructural evidence of two agents in experimentally infected chimpanzees, Science, 205, 197, 10.1126/science.451589 Schiffer, 1982, Platelet transfusion from single donors, Sounding Board, 307, 245 Stevens, 1984, Hepatitis B virus antibody in blood donors and the occurrence of non-A, non-B hepatitis in transfusion recipients, Annals of Internal Medicine, 101, 733, 10.7326/0003-4819-101-6-733 Koziol, 1986, Antibody to hepatitis B core antigen as a paradoxical marker for non-A, non-B hepatitis agents in donated blood, Annals of Internal Medicine, 104, 488, 10.7326/0003-4819-104-4-488 Silverstein, 1984, Should donor blood be screened for elevated alanine aminotransferase levels?, Journal of the American Medical Association, 252, 2839, 10.1001/jama.252.20.2839 Alter, 1984, Indirect tests to detect the non-A, non-B hepatitis carrier state, Annals of Internal Medicine, 101, 859, 10.7326/0003-4819-101-6-859 Anderson, 1987, Surrogate testing for non-A, non-B hepatitis, Lancet, i, 912, 10.1016/S0140-6736(87)92875-3 Contreras, 1987, Testing of blood donations for non-A, non-B hepatitis, Lancet, ii, 270, 10.1016/S0140-6736(87)90849-X Dow, 1987, Non-A, non-B hepatitis surrogate testing of blood donations, Lancet, i, 1366, 10.1016/S0140-6736(87)90662-3 Gillon, 1987, Non-A, non-B hepatitis surrogate testing of blood donations (Letter to the Editor), Lancet, i, 1366 Bove, 1987, Transfusion-associated hepatitis and AIDS, New England Journal of Medicine, 317, 242, 10.1056/NEJM198707233170411 Federal Register, volume 37, number 106, title 42, part 73.775, p 10937 Alter, 1977, How frequent is post-transfusion hepatitis after the introduction of third generation donor screening for hepatitis B?, 32, 346 Seeff, 1975, VA cooperative study post-transfusion hepatitis, 1969–1974: Incidence and characteristics of hepatitis and possible risk factors, American Journal of Medical Sciences, 270, 355, 10.1097/00000441-197509000-00018 Knodell, 1975, Etiological spectrum of post-transfusion hepatitis, Gastroenterology, 69, 1278, 10.1016/S0016-5085(19)32325-X Alter, 1972, Post-transfusion hepatitis after exclusion of commercial and hepatitis B antigen positive donors, Annals of Internal Medicine, 77, 691, 10.7326/0003-4819-77-5-691 Goldfield, 1975, Some epidemiologic studies of transfusion-associated hepatitis, 141 Bove, 1986, Transfusion-transmitted diseases: Current problems and challenges, volume XIV, 123 Guerrero, 1983, Transfusion malaria in the United States, 1972–1981, Annals of Internal Medicine, 99, 221, 10.7326/0003-4819-99-2-221 Conrad, 1981, Diseases transmissible by blood transfusion: Viral hepatitis and other infectious disorders, 18, 122 1981, 6 Wittner, 1982, Successful chemotherapy of transfusion babesiosis, Annals of Internal Medicine, 96, 601, 10.7326/0003-4819-96-5-601 Francioli, 1981, Response of babesiosis to pentamidine therapy, Annals of Internal Medicine, 94, 326, 10.7326/0003-4819-94-3-326 Jacoby, 1980, Treatment of transfusion-transmitted babesiosis by exchange transfusion, New England Journal of Medicine, 303, 1098, 10.1056/NEJM198011063031906 Bowden, 1986, Cytomegalovirus immune globulin and seronegative blood products to prevent primary cytomegalovirus infection after marrow transplantation, New England Journal of Medicine, 314, 1006, 10.1056/NEJM198604173141602 Yeager, 1981, Prevention of transfusion-acquired cytomegalovirus infection in newborn infants, The Journal of Pediatrics, 98, 281, 10.1016/S0022-3476(81)80662-2 Rubin, 1985, Multicenter seroepidemiologic study of the impact of cytomegalovirus infection on renal transplantation, Transplantation, 40, 243, 10.1097/00007890-198509000-00004 Adler, 1985, Transfusion-associated cytomegalovirus infections in seropositive cardiac surgery patients, The Lancet, ii, 743, 10.1016/S0140-6736(85)90628-2 1982, Morbidity and Mortality Weekly Report, 31, 652 Ammann, 1983, Acquired immunodeficiency in an infant: possible transmission by means of blood products, Lancet, i, 956, 10.1016/S0140-6736(83)92082-2 Eckholm, 1986, The New York Blood Bank says 700 might have got AIDS virus, New York Times July, 17, 1 1985, Morbidity and Mortality Weekly Repoort, 34, 375 Sayers, 1986, HLA antibodies as a cause of false-positive reactions in screening enzyme immunoassays for antibody to human T-lymphotropic virus type III, Transfusion, 26, 113, 10.1046/j.1537-2995.1986.26186124012.x Schüpbach, 1985, Antibodies to HTLV-III in Swiss patients with AIDS and pre-AIDS and in groups at risk for AIDS, New England Journal of Medicine, 312, 265, 10.1056/NEJM198501313120502 van den Berg, 1986, Seroconversion to HTLV-III in haemophiliacs given heat-treated factor VIII concentrates, Lancet, i, 803, 10.1016/S0140-6736(86)91814-3 Levine, 1985, The acquired immunodeficiency syndrome in persons with hemophilia, Annals of Internal Medicine, 103, 723, 10.7326/0003-4819-103-5-723 Bird, 1985, Haemophilia and AIDS, Lancet, i, 162, 10.1016/S0140-6736(85)91929-4 Bloom, 1985, Haemophilia and AIDS, Lancet, i, 336, 10.1016/S0140-6736(85)91103-1 Barrowcliffe, 1986, Factor VIII degradation products in heated concentrates, Lancet, i, 1448, 10.1016/S0140-6736(86)91599-0 1986, Morbidity and Mortality Weekly Report, 35, 133 Wells, 1986, Inactivation and partition of human T-cell lymphotropic virus, type III, during ethanol fractionation of plasma, Transfusion, 26, 210, 10.1046/j.1537-2995.1986.26286152919.x